Anti-Inflammatory Biologics Market Size to reach USD 149.80 Billion

 The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.

Get Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/anti-inflammatory-biologics-market-102733

North America

United States, Canada and Mexico

Europe

Germany, UK, France, Italy, Russia and Turkey etc.

Asia-Pacific

China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc.

South America

Brazil, Argentina, Columbia etc.

Middle East & Africa

Saudi Arabia, UAE, Egypt, Nigeria and South Africa

               Diseases to Foster Growth

The rising cases of autoimmune inflammatory diseases such as psoriasis, rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel diseases, ulcerative colitis, and others is a key factor driving the anti-inflammatory biologics market. According to the National Psoriasis Foundation, in 2017, 125 million people across the world were estimated to have psoriasis. As per the World Health Organization, Osteoarthritis is one of the ten most disabling diseases in developed countries, which affects 9.6% of men and 18.0% of women aged over 60 years worldwide. Moreover, the World Health Organization also states 80% of those with osteoarthritis will have limitations in movement, and 25% cannot perform their major daily activities of life. Besides, the rapid adoption of biologics for the treatment of inflammatory diseases will support the market trajectory in the foreseeable future.

Lack of Awareness regarding Biologics to Obstruct Market

The lack of awareness regarding biologics as an effective treatment of psoriasis and rheumatoid arthritis is a key factor restricting the growth of the market. Disease-modifying Anti-rheumatic Drugs (DMARDs) such as methotrexate is used as the first-line of treatment for rheumatoid arthritis. While in psoriasis topical drugs such as corticosteroids, Vitamin D analogues are used as first-line of treatment. Whereas, biologics are used as third-line of treatment for both diseases. The partiality towards Disease-modifying Anti-rheumatic Drugs and disfavor for biologics will impede the market share during the forecast period.

Speak To Our Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-inflammatory-biologics-market-102733

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Comments

Popular posts from this blog

Pulse Oximeters Market Rising in United States | Fortune Business Insights

Behandlung von idiopathischer entzündlicher Myopathie Marktgröße, Anteil, Wachstum, Berichtsanalyse 2023

Eyewear Market In United States | Fortune Business Insights